Melbourne-based joint venture Shepparton Partners Collective has lost its appeal of a $1.2 million judgment that found it infringed software developer QAD’s copyright by failing to pay a transfer fee to retain the licence after it acquired the iconic SPC Ardmona cannery in Victoria from Coca-Cola Amatil for $40 million.
A court has summarily dismissed a lawsuit accusing the Victorian government of acting unlawfully by improving the Western Highway and threatening to harm six ‘directions’ trees of cultural significance to the Djab Wurrung people.
McDonald’s Australia has been joined as a second respondent in a union-led lawsuit that accuses the fast food giant of “conspiring to deliberately deny workers their breaks”.
A committee report recommending passage of the Morrison government’s controversial class action reform bill was tabled in federal parliament Monday, with the committee’s chair touting the proposed legislation as putting an end to funders’ “windfall” profits and Labor panning the bill as a study in “Orwellian gaslighting”.
Embattled technology company Nuix has been hit with a shareholder class action over its $1.8 billion December float on the ASX.
Law firm Sparke Helmore acted negligently by failing to adequately advise a New South Wales property developer about extension of time notices that were needed to prevent two lucrative contracts from falling through, a judge has found.
A class action on behalf of people who claim they developed non-Hodgkin lymphoma after using Monsanto’s Roundup weed killer will argue the agrochemical giant should be hit with exemplary damages for its negligence in selling the herbicide, which the company allegedly knew caused cancer.
ASIC has won its bid to wind up accused Sydney fraudster Melissa Caddick’s company and appoint final receivers to realise her assets, paving the way for some repayment to the dozens of family and friends who invested with Caddick and are still owed $23.5 million.
The Finance Sector Union has launched legal proceedings in the Fair Work Commission against the Commonwealth Bank for allegedly sacking an employee who breached a “draconian” salary secrecy clause.
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
